课题基金 / 基金详情

Experimental medicine approach linking brain and peripheral immune mechanisms mediating sickness behaviours in people with rheumatoid arthritis

Experimental medicine approach linking brain and peripheral immune mechanisms mediating sickness behaviours in people with rheumatoid arthritis
连接大脑和外周免疫机制介导类风湿性关节炎患者疾病行为的实验医学方法
批准号:
MR/S035753/1
负责人:
Jonathan Cavanagh
金额:
$153.19万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
未结题
起止时间:
2019 至 --

项目摘要

项目成果

Jonathan Cavanagh的其他基金

相似基金

相关文献

中文摘要
翻译
疾病行为-包括情绪变化和疲劳-发生在免疫介导的炎症性疾病(IMID),如类风湿性关节炎(RA)的人是一个主要的未满足的临床需求。这种行为对预后、治疗反应和结果具有显著的额外负面影响。重要的是,它们始终是患者最关心的问题之一。在这一领域的治疗进展需要更深刻的理解的机制的基础症状在这里,我们建议使用一个精致的特定的干预证明在类风湿关节炎的好处,靶向肿瘤坏死因子,利用机械的理解外周免疫大脑通信驱动疾病的行为。我们将联合收割机与高度创新的神经影像学技术相结合,以获得迄今为止仅在动物研究中获得的人体机制数据。该提案将建立在少量先前研究的基础上,这些研究使用神经成像来显示IMID(如RA)背景下的异常脑通路以及TNF抑制后这些神经成像参数的变化。广泛的临床前和动物研究表明,一种将外周炎性蛋白与疾病行为联系起来的假定机制是单核细胞进入大脑,随后受单核细胞衍生的TNF影响的神经变化,最明显的是通过神经元能作用。因此,使用超高场(7 T)MRI和MRS以及创新的SPECT-CT来测量循环标记单核细胞的CNS浸润,我们将检验以下假设:i)抗TNF治疗将影响脑网络连接和脑中谷氨酸定量的变化。ii)RA患者将显示与疾病行为相关的脑网络连接和谷氨酸定量的变化。这些影像学终点(加上次要认知行为、临床和外周免疫终点)将在基线和4周后在多达50名RA患者中进行测量,这些患者以1:1的比例随机接受抗TNF抗体或安慰剂输注治疗。基线数据将使我们能够测试两个关键的假设,外周单核细胞浸润和神经元兴奋毒性的机制有助于疾病的行为。TNF抑制剂管理将解决我们的第三个hypothesis.Together,这项研究将提供深入了解的机制,subserve疾病的行为,从而新的工具和目标,以支持未来的开发创新的药物治疗类风湿关节炎和其他IMID的行为。
英文摘要
Sickness behaviours - including mood change and fatigue - that occur in people with immune-mediated inflammatory disorders (IMIDs) such as rheumatoid arthritis (RA) are a major unmet clinical need. Behaviours of this kind have a significant additional negative impact on prognosis, therapeutic response and outcomes. Importantly, they are consistently among the most commanding of patients' concerns. Therapeutic progress in this area requires a more profound understanding of the mechanisms underpinning the symptoms Here we propose to use an exquisitely specific intervention of proven benefit in RA, targeting TNF, to leverage a mechanistic understanding of the peripheral immune to brain communications that drive sickness behaviour. We will combine the administration of a clinically indicated therapy with highly innovative neuroimaging technologies to obtain mechanistic data in humans that has hitherto only been available in animal studies. The proposal will build on a small number of prior studies that have used neuroimaging to show abnormal brain pathways in the context of IMIDs such as RA and changes in these neuroimaging parameters following TNF inhibition. A putative mechanism linking peripheral inflammatory proteins to sickness behaviour, implicated by extensive pre-clinical and animal studies, is monocyte ingress to the brain and subsequent neural change effected by monocyte-derived TNF, most notably via glutamatergic action. Thus using ultra high-field (7T) MRI and MRS alongside innovative SPECT-CT to measure CNS infiltration by circulating labelled monocytes, we will test the following hypotheses: i) Anti-TNF therapy will effect changes in brain network connectivity and glutamate quantification in the brain.ii) RA patients will show changes in brain network connectivity and glutamate quantification correlated with sickness behaviours.iii) RA patients will show changes in monocyte infiltration to the brain that are correlated with sickness behaviours.These imaging endpoints (plus secondary cognitive-behavioural, clinical and peripheral immune endpoints) will be measured at baseline and 4 weeks later in up to 50 patients with RA, randomised 1:1 to treatment with anti-TNF antibody or placebo infusion. The baseline data will allow us to test the two key hypotheses of peripheral monocyte infiltration and glutamatergic excitoxicity as mechanisms contributing to sickness behaviour. TNF inhibitor administration will address our third hypothesis.Together this study will provide insight to the mechanisms that sub-serve sickness behaviours, and thereby new tools and targets to support future development of innovative drug treatments for such behaviours in RA and other IMIDs.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1136/jnnp-2022-328903
发表时间: 2022-05-23
期刊: Journal of neurology, neurosurgery, and psychiatry
影响因子: --
作者: []
通讯作者:
DOI: 10.1002/pul2.12192
发表时间: 2023-01
期刊: PULMONARY CIRCULATION
影响因子: 2.6
作者: [Dunmore, Benjamin J., Upton, Paul D., Auckland, Kate, Samanta, Romit J., Lyons, Paul A., Smith, Kenneth G. C., Graf, Stefan W., Summers, Charlotte, Morrell, Nicholas]
通讯作者: Morrell, Nicholas
Peripheral inflammation is associated with alterations in brain biochemistry and mood: evidence from in vivo proton magnetic resonance spectroscopy study
周围炎症与大脑生化和情绪的改变有关:来自体内质子磁共振波谱研究的证据
DOI: 10.1515/pac-2022-1119
发表时间: 2023
期刊: Pure and Applied Chemistry
影响因子: 1.8
作者: [Mumuni A]
通讯作者: Mumuni A
Regulation of ICAM-1 in human neutrophils
人中性粒细胞中 ICAM-1 的调节
DOI: 10.17863/cam.107511
发表时间: 2024
期刊:
影响因子: --
作者: [Farahi N]
通讯作者: Farahi N
Evaluating the role of IL-17A as an orchestrator of peripheral-central cross talk in depressive symptoms
  • 批准号:
    MR/Z503988/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $203.16万
  • 财政年份:
    2024
  • 负责人:
    Jonathan Cavanagh
  • 依托单位:
国内基金
海外基金
新型二维/三维双体系癌症研究模型的建立
  • 批准号:
    32070796
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    王霞
  • 依托单位:
Chinese Journal of Integrative Medicine
  • 批准号:
    81224004
  • 项目类别:
    专项基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2012
  • 负责人:
    徐浩
  • 依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
基于循证医学本体论的临床元数据语言研究